Cited by 214Alzheimer's disease research and treatmentsHeat shock proteins researchNeuroinflammation and Neurodegeneration Mechanisms

The Hsp90 cochaperone, FKBP51, increases Tau stability and polymerizes microtubules

Open access
Jinwal, Umesh K., Koren, John, Borysov, Sergiy I., Schmid, Andreas B., Abisambra, Jose F., Blair, Laura J., Johnson, Amelia G., Jones, Jeffrey R. +6 more·2010·The Journal of Neuroscience

Abstract

Imbalanced protein load within cells is a critical aspect for most diseases of aging. In particular, the accumulation of proteins into neurotoxic aggregates is a common thread for a host of neurodegenerative diseases. Our previous work demonstrated that age-related changes to the cellular chaperone repertoire contributes to abnormal buildup of the microtubule-associated protein tau that accumulates in a group of diseases termed tauopathies, the most common being Alzheimer's disease. Here, we show that the Hsp90 cochaperone, FK506-binding protein 51 (FKBP51), which possesses both an Hsp90-interacting tetratricopeptide domain and a peptidyl-prolyl cis-trans isomerase (PPIase) domain, prevents tau clearance and regulates its phosphorylation status. Regulation of the latter is dependent on the PPIase activity of FKBP51. FKB51 enhances the association of tau with Hsp90, but the FKBP51/tau interaction is not dependent on Hsp90.In vitro FKBP51 stabilizes microtubules with tau in a reaction depending on the PPIase activity of FKBP51. Based on these new findings, we propose that FKBP51 can use the Hsp90 complex to isomerize tau, altering its phosphorylation pattern and stabilizing microtubules.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1523/jneurosci.4815-09.2010

Cites

36 of 36 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The Hsp90:FKBP51 system acts in tau proteostasis, raising tau stability and changing its phosphorylation.

    “Hsp90:FKBP51 functions in tau proteostasis, increasing its stability and altering phosphorylation states”
  • Largely mediated via the FK1 domains, FKBP51 and FKBP52 also act as antagonists in regulating the phosphorylation state of the tau protein and its proper recycling.

    “Largely mediated via the FK1 domains, FKBP51 and FKBP52 also act as antagonists in regulating the phosphorylation state of the tau protein and its proper recycling [18,19].”
  • One or more cochaperones could be more specific drug targets with fewer adverse consequences.

    “Recent data suggest that one or more of these cochaperones could be more specific drug targets with fewer adverse consequences [39, 93].”

    From FKBP51 and FKBP52 in signaling and disease (2011) · cites this paper as [39]

  • FKBP51 preserves tau levels but reduces its phosphorylation, perhaps by cooperating with a set of phosphatases.

    “Recently, FKBP51 was shown to preserve tau levels, but reduce its phosphorylation, perhaps by cooperating with a set of phosphatases [39].”

    From FKBP51 and FKBP52 in signaling and disease (2011) · cites this paper as [39]

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Jinwal, U. K., Koren, J., Borysov, S. I., Schmid, A. B., Abisambra, J. F., Blair, L. J., Johnson, A. G., Jones, J. R., Shults, C. L., O'Leary, J. C., Jin, Y., Buchner, J., Cox, M. B., & Dickey, C. A.
Affiliations
  • University of South Florida (US)
  • The University of Texas at El Paso (US)
  • Technical University of Munich (DE)
Venue
The Journal of Neuroscience
Published
2010-01-13
Volume
30
Issue
2
Pages
591-599
ISSN
  • 0270-6474 (ISSN-L)
  • 1529-2401
OpenAlex
W2084436053
Cited by
214
References
36
Citations by year
2026: 14 · 2025: 12 · 2024: 10 · 2023: 13 · 2022: 5 · 2021: 10 · 2020: 6 · 2019: 14 · 2018: 9 · 2017: 13 · 2016: 14 · 2015: 20 · 2014: 12 · 2013: 18 · 2012: 13
FWCI
13.26
Type
journal article
Language
en
Open access
Locations
  • Journal of Neuroscience (publishedVersion, cc-by-nc-sa)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • CurePSP
  • Rosalinde and Arthur Gilbert Foundation
  • Elitenetzwerk Bayern
  • National Institute on Aging (R00AG031291)
Topics
  • Health Sciences › Medicine › Physiology › Alzheimer's disease research and treatments
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Heat shock proteins research
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
Keywords
FKBP51, Hsp90 co-chaperone, tau protein, tau phosphorylation, microtubule stabilization, peptidyl-prolyl isomerase, tauopathy, Alzheimer's disease, protein aggregation, aging, molecular chaperones, tetratricopeptide repeat domain
MeSH terms
Tacrolimus Binding Protein 5, Animals, Brain, Cell Line, Transformed, Chymotrypsin, Female, Gene Expression Regulation, Humans, Male, Mice, Inbred C57BL, Microtubules, Mutation, Oocytes, Transfection, Xenopus, Benzoquinones, tau Proteins, HSP90 Heat-Shock Proteins, Peptidylprolyl Isomerase, Tacrolimus Binding Proteins, RNA, Small Interfering, Lactams, Macrocyclic, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review